Aesther Healthcare Acquisition - SIC # 6726 - UNIT INVESTMENT TRUSTS, FACE-AMOUNT CERTIFICATE OFFICES, AND CLOS

Ticker Exchange SIC # Website Latest Ticker
AEHA Nasdaq 6726 https://www.aestherhealthcarespac.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aesther Healthcare Acquisition

Aesther and Ocean Biomedical Announce Shareholder Approval of Business Combination - Feb 6th, 2023 2:15 pm
Ocean Biomedical Chairman Chirinjeev Kathuria on Going Public Via SPAC - Feb 2nd, 2023 7:11 pm
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Measures regarding Excise Tax - Feb 1st, 2023 10:43 pm
Ocean Biomedical Chairman Kathuria on Going Public Via SPAC - Jan 31st, 2023 2:40 pm
Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other Cancers - Jan 30th, 2023 2:15 pm
Ocean Biomedical Provides Corporate Update and Company Summary - Jan 24th, 2023 2:15 pm
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Definitive Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc. - Jan 13th, 2023 10:05 pm
Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination - Dec 16th, 2022 1:30 pm
Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination - Dec 13th, 2022 2:15 pm
Novel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting by Ocean Biomedical’s Scientific Co-founder, Dr. Jake Kurtis, unveiling the potential for a new class of Antimalarial Drugs. - Nov 1st, 2022 1:15 pm
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 Million - Oct 5th, 2022 11:45 am
Building on Their Innovative mRNA Vaccine Program, Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) Recently Announced Business Combination to Support the Discovery of a New Class of Antimalarial Drugs. - Sep 22nd, 2022 11:45 am
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc. - Sep 19th, 2022 11:45 am
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion Capital - Sep 8th, 2022 12:07 pm
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%, Announced by Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) - Sep 6th, 2022 11:59 am
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Which Kill Glioblastoma and Block the Metastasis of Malignant Melanoma Cells to the Lung By Over 90% Announced by Ocean Biomedical and Aesther Healthcare (NASDAQ: AEHA) - Sep 6th, 2022 11:45 am
Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ - Aug 31st, 2022 11:47 am
Aesther Healthcare Acquisition Corp. and United Gear & Assembly, Inc. (High Precision Gears for Electric Vehicles) Announce Definitive Merger Agreement - May 27th, 2022 12:15 pm
How Much Of Aesther Healthcare Acquisition Corp. (NASDAQ:AEHA) Do Institutions Own? - Feb 12th, 2022 11:01 am